Two inhibitors of yeast plasma membrane ATPase 1 (ScPma1p): toward the development of novel antifungal therapies

Given that many antifungal medications are susceptible to evolved resistance, there is a need for novel drugs with unique mechanisms of action. Inhibiting the essential proton pump Pma1p, a P-type ATPase, is a potentially effective therapeutic approach that is orthogonal to existing treatments. We i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottilie, Sabine, Goldgof, Gregory M., Cheung, Andrea L., Walker, Jennifer L., Vigil, Edgar, Allen, Kenneth E., Antonova-Koch, Yevgeniya, Slayman, Carolyn W., Suzuki, Yo, Durrant, Jacob D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820243/
https://www.ncbi.nlm.nih.gov/pubmed/29464421
http://dx.doi.org/10.1186/s13321-018-0261-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820243/
https://www.ncbi.nlm.nih.gov/pubmed/29464421
http://dx.doi.org/10.1186/s13321-018-0261-3

Ejemplares similares